|
Volumn 75, Issue 3, 2001, Pages 191-197
|
Interferon-β1a administration results in a transient increase of serum amyloid A protein and C-reactive protein: Comparison with other markers of inflammation
|
Author keywords
C Reactive protein; Interferon beta; Mononuclear leukocytes; Multiple sclerosis; Serum amyloid A protein
|
Indexed keywords
AMYLOID A PROTEIN;
BETA 2 MICROGLOBULIN;
BETA1A INTERFERON;
C REACTIVE PROTEIN;
CD16 ANTIGEN;
CD86 ANTIGEN;
HLA DR ANTIGEN;
NEOPTERIN;
RECOMBINANT BETA INTERFERON;
AUTACOID;
BETA INTERFERON;
SERUM AMYLOID A;
ADULT;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DOSE TIME EFFECT RELATION;
FATIGUE;
FEMALE;
FEVER;
HEADACHE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INFLAMMATION;
MALE;
MULTIPLE SCLEROSIS;
MYALGIA;
NAUSEA;
PRIORITY JOURNAL;
PROTEIN SECRETION;
CLINICAL TRIAL;
IMMUNOLOGY;
LYMPHOCYTE ACTIVATION;
METABOLISM;
MIDDLE AGED;
MONONUCLEAR CELL;
PATHOPHYSIOLOGY;
ADULT;
C-REACTIVE PROTEIN;
FEMALE;
HUMANS;
INFLAMMATION MEDIATORS;
INTERFERON-BETA;
LEUKOCYTES, MONONUCLEAR;
LYMPHOCYTE ACTIVATION;
MALE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
SERUM AMYLOID A PROTEIN;
|
EID: 0035862129
PISSN: 01652478
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-2478(00)00310-2 Document Type: Article |
Times cited : (20)
|
References (39)
|